Cancer Clinical Trial
— mHealthAYAOfficial title:
An mHealth Positive Psychology Intervention to Reduce Cancer Burden in Young Adult Cancer Survivors
We aim to refine and pilot test an 8-week phone- and app-based intervention to promote hope, and thereby mitigate life disruption caused by cancer diagnosis and treatment, among young adults (YAs); our proposal involves (Aim 1) formative research among YA survivors and healthcare providers; and (Aim 2) an randomized controlled trial (RCT) of the intervention vs. attention control among 150 YA cancer survivors. The proposed research is innovative in its use of: 1) a novel intervention target - hope - as a mechanism for addressing goal-disruption and quality of life (QOL) among YA survivors; and 2) novel mHealth components and population-based recruitment strategy (via social media) that are particularly relevant to YA survivors and those with potentially limited access to healthcare. This proposal has potential high impact due to the number of YA cancer survivors for whom the intervention may be relevant, the intervention's potential utility in enhancing hope and QOL among YAs, and its reach/scalability.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | December 31, 2024 |
Est. primary completion date | August 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 39 Years |
Eligibility | Inclusion Criteria: - Diagnosis of stage I-IV cancer from age 20-39 - Completion of curative treatment (surgery, chemotherapy and/or radiation) within three years of study enrollment - No significant psychological disabilities - Able to complete forms and understand instructions in English - Smartphone access - Aim 2: Able to commit to 8-week remotely delivered study Exclusion Criteria: - Completion of curative treatment (surgery, chemotherapy and/or radiation) over three years ago or currently in treatment - Significant psychological disabilities |
Country | Name | City | State |
---|---|---|---|
United States | George Washington University | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
George Washington University | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Retention | =>85% retention | 2 months (end-of-treatment; EOT) | |
Primary | Retention | =>85% retention | 6-month (follow-up; FU) | |
Primary | Adherence | >75% adherence to intervention components | 2 months (end-of-treatment; EOT) | |
Primary | Adherence | >75% adherence to intervention components | 6-month (follow-up; FU) | |
Primary | Acceptability | >75% participants reporting high satisfaction (3 or 4 on scale of 0=not at all to 4=very) | 2 months (end-of-treatment; EOT) | |
Primary | Acceptability | >75% report yes to "would you recommend this program to your friends who are cancer survivors?" | 2 months (end-of-treatment; EOT) | |
Primary | Hope, per Snyder's Hope Scale | Higher scores indicate higher hope (scale: 6-48) | 6-month (follow-up; FU) | |
Secondary | Hope, per Snyder's Hope Scale | Higher scores indicate higher hope (scale: 6-48) | 2 months (end-of-treatment; EOT) | |
Secondary | Quality of Life - Patient-Reported Outcome Measurement Information System (PROMIS) Global Health scale | Higher scores indicate higher Quality of Life (scale 0-100) (PMCID: PMC2724630) | 2 months (end-of-treatment; EOT) | |
Secondary | Quality of Life - Patient-Reported Outcome Measurement Information System (PROMIS) Global Health scale | Higher scores indicate higher Quality of Life (scale 0-100) (PMCID: PMC2724630) | 6-month (follow-up; FU) | |
Secondary | Quality of Life - Rand Medical Outcome Study 36-Item Short Form Health Survey (SF-36) | Higher scores indicate higher Quality of Life (scale: 0-100) (https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html) | 2 months (end-of-treatment; EOT) | |
Secondary | Quality of Life - Rand Medical Outcome Study 36-Item Short Form Health Survey (SF-36) | Higher scores indicate higher Quality of Life (scale: 0-100) (https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html) | 6-month (follow-up; FU) | |
Secondary | Patient Health Questionnaire - 4 item (PHQ-4): Depression and anxiety symptoms | Higher score indicates greater depressive and anxiety symptoms (scale: 0-12) | 2 months (end-of-treatment; EOT) | |
Secondary | Patient Health Questionnaire - 4 item (PHQ-4): Depression and anxiety symptoms | Higher score indicates greater depressive and anxiety symptoms (scale: 0-12) | 6-month (follow-up; FU) | |
Secondary | Physical activity | Number of days in the past 30 days, engaged in physical activity | 2 months (end-of-treatment; EOT) and 6-month (follow-up; FU) | |
Secondary | Alcohol use | Number of days in the past 30 days, consumed alcohol | 2 months (end-of-treatment; EOT) and 6-month (follow-up; FU) | |
Secondary | Tobacco use | Number of days in the past 30 days, used any tobacco product | 2 months (end-of-treatment; EOT) and 6-month (follow-up; FU) | |
Secondary | Cannabis use | Number of days in the past 30 days, used cannabis | 2 months (end-of-treatment; EOT) and 6-month (follow-up; FU) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|